Arsenic sulfide reverses cisplatin resistance in non‐small cell lung cancer in vitro and in vivo through targeting PD‐L1

Arsenic sulfide reverses cisplatin resistance in non‐small cell lung cancer in vitro and in vivo through targeting PD‐L1

Abstract Background Recent studies have found that programmed death ligand 1 (PD‐L1) might be involved in chemotherapy resistance in non‐small cell lung cancer (NSCLC). Arsenic sulfide (As4S4) has been recognized to have antitumor activities and enhance the cytotoxic effect of chemotherapy drugs. In...

Full description

Bibliographic Details
Main Authors: Wei Tian, Yinping Sun, Yuping Cheng, Xiao Ma, Weina Du, Wenna Shi, Qisen Guo
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Thoracic Cancer
Subjects:
As4S4
chemoresistance
cisplatin
NSCLC
PD‐L1
Online Access:https://doi.org/10.1111/1759-7714.14136

Internet

https://doi.org/10.1111/1759-7714.14136

Similar Items